Biocompare.com RSS feed http://www.biocompare.com/ © 2010 Biocompare.com Sun, 01 Aug 2010 02:01:50 GMT http://backend.userland.com/rss RSS.NET: http://www.rssdotnet.com/ BETHESDA, Md., July 29, 2010 - Researchers seeking to learn more about stroke by studying how the body responds to toxins in snake venom are this week releasing new findings that they hope will aid in the development of therapies for heart disease and, surprisingly, cancer. http://news.biocompare.com/newsstory.asp?id=335980 Biocompare.com Fri, 30 Jul 2010 14:15:00 GMT The Food and Drug Administration (FDA) received reports of malignancies in children using tumor necrosis factor a (TNF) blockers, raising concerns of an associated risk and prompting an investigation. Researchers from the FDA set out to identify all reports of malignancy in children using infliximab, etanercept, and adalimumab and their report is published in the August issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology. http://news.biocompare.com/newsstory.asp?id=335976 Biocompare.com Fri, 30 Jul 2010 14:07:00 GMT Louisville, Ky. -- People with a family history of male breast cancer perceive themselves to be at higher risk of developing the disease than do patients with a family history of female breast cancer; however those with male breast cancer in their families are less likely to know about or seek genetic testing than those with a family history of female breast cancer, according to a study led by researchers at the University of Louisville's James Graham Brown Cancer Center. http://news.biocompare.com/newsstory.asp?id=335969 Biocompare.com Fri, 30 Jul 2010 13:43:00 GMT HOUSTON - Researchers have discovered an enzyme crucial to a type of DNA repair that also causes resistance to a class of cancer drugs most commonly used against ovarian cancer. http://news.biocompare.com/newsstory.asp?id=335964 Biocompare.com Fri, 30 Jul 2010 13:25:00 GMT A type of prostate cell that has been largely ignored by cancer researchers can, in fact, trigger malignant prostate cancer, according to new studies by Howard Hughes Medical Institute (HHMI) scientists and their colleagues. http://news.biocompare.com/newsstory.asp?id=335963 Biocompare.com Fri, 30 Jul 2010 13:21:00 GMT ATLANTA-July 29, 2010-Twenty-five years after publishing the mnemonic "ABCD" to facilitate the early diagnosis of melanoma, the group who came up with that moniker says early detection remains a key factor in lowering mortality from malignant melanoma. Darrell S. Rigel, M.D. and colleagues from the Ronald O. Perelman Department of Dermatology at New York University School of Medicine say that, despite all of the advances in melanoma diagnosis, timely recognition, detection, and rapid treatment of melanoma remain critical. Their report appears online on CA First Look, and will appear in the September/October issue of CA: A Cancer Journal for Clinicians. http://news.biocompare.com/newsstory.asp?id=335962 Biocompare.com Fri, 30 Jul 2010 13:20:00 GMT UCLA scientists have identified for the first time a cell-of-origin for human prostate cancer, a discovery that could result in better predictive and diagnostics tools and the development of new and more effective targeted treatments for the disease. http://news.biocompare.com/newsstory.asp?id=335950 Biocompare.com Fri, 30 Jul 2010 12:05:00 GMT Scientists at the Buck Institute for Age Research have discovered that a particular family of enzymes are involved in the breakdown of proteins that modify the production of toxic fragments that lead to the pathology of Huntington's disease. These enzymes, matrix metalloproteinases (MMPs), provide new targets for drug therapies for the disease - targets that have already been shown to respond to cancer drugs currently in clinical development. Results of the research, from the laboratories of Buck faculty members Lisa Ellerby, Ph.D. and Robert Hughes, Ph.D., appear as the cover story in the July 29, 2010 edition of Neuron. http://news.biocompare.com/newsstory.asp?id=335761 Biocompare.com Thu, 29 Jul 2010 13:07:00 GMT Grown-ups aren't the only ones making exciting scientific discoveries these days. Two middle school students from Wisconsin joined a team of scientists who are reporting the first glimpse of the innermost structure of a key bacterial enzyme. It helps activate certain antibiotics and anti-cancer agents so that those substances do their job. Their study appears in ACS' weekly journal Biochemistry. The student co-authors of the study are from Edgewood Campus Middle School in Madison and participated in Project CRYSTAL, a special program that provides middle school students with hands-on laboratory experience. http://news.biocompare.com/newsstory.asp?id=335755 Biocompare.com Thu, 29 Jul 2010 11:54:00 GMT Scientists in Japan may have developed a way to accurately predict those patients who will resist treatment with imatinib, which is the standard of care for chronic myeloid leukemia (CML). http://news.biocompare.com/newsstory.asp?id=335750 Biocompare.com Thu, 29 Jul 2010 11:31:00 GMT